Biotène Lozenges

Biotène is a widely recognized oral care brand specialized in addressing symptoms of dry mouth (xerostomia). Originally developed by Laclede, Inc. in the United States, the brand became famous for its enzyme-based formula designed to mimic natural saliva protection.

Over the decades, the brand's ownership has transitioned through major pharmaceutical mergers. It was acquired by GlaxoSmithKline (GSK) in the mid-2000s. In 2022, GSK spun off its consumer healthcare division into a new independent company called Haleon. Today, Biotène is part of the Haleon portfolio, which is headquartered in the United Kingdom. Manufacturing occurs in various global facilities depending on the specific product line and regional market needs, though primarily in North America and Europe.